Ose Pharma Sa Stock Total Asset

OSE Stock  EUR 8.21  0.12  1.48%   
OSE Pharma SA fundamentals help investors to digest information that contributes to OSE Pharma's financial success or failures. It also enables traders to predict the movement of OSE Stock. The fundamental analysis module provides a way to measure OSE Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OSE Pharma stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

OSE Pharma SA Company Total Asset Analysis

OSE Pharma's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current OSE Pharma Total Asset

    
  101.88 M  
Most of OSE Pharma's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OSE Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Based on the latest financial disclosure, OSE Pharma SA has a Total Asset of 101.88 M. This is 98.65% lower than that of the Biotechnology sector and 94.84% lower than that of the Health Care industry. The total asset for all France stocks is 99.65% higher than that of the company.

OSE Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OSE Pharma's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OSE Pharma could also be used in its relative valuation, which is a method of valuing OSE Pharma by comparing valuation metrics of similar companies.
OSE Pharma is currently under evaluation in total asset category among its peers.

OSE Fundamentals

About OSE Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze OSE Pharma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OSE Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OSE Pharma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in OSE Stock

OSE Pharma financial ratios help investors to determine whether OSE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OSE with respect to the benefits of owning OSE Pharma security.